ClearPoint Neuro, Inc.
- CLPT
- NASDAQ
- Medical devices
- MRI-Guided Neurosurgery
- Medical Devices (Brain)
$9.17
Today +1.10%Quote Oct 19, 2026, 08:00 PM UTC
−33.99%over the last month
Max drawdown −42.6%From 1-month high −42.6%3 months −39.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About ClearPoint Neuro
ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure.
Where the money comes from
Q2 2026 revenue $10.9M
- Biologics And Drug Delivery$4.0M37.0%
- Capital Equipment And Software$1.3M11.9%
- Biologics And Drug Delivery - Disposable Products$943,0008.7%
- Capital Equipment And Software - Systems and Software Products$881,0008.1%
- Capital Equipment And Software - Services$416,0003.8%
- Other / not reported$3.3M30.4%
Sector
Healthcare
Industry
Medical devices
Exchange
NASDAQ
Employees
172
Market value
$279.7M
Quote Oct 19
Floor
$8.30
9.5% below price
Resistance
$9.24
0.8% above price
Price vs analyst targets
3 analysts
Lowest target
$22.00Highest target
$25.00
$22.00Highest target
$25.00
- Price $9.17
- Average target $23.50
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 156% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CLPTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free